COMMUNIQUÉS West-GlobeNewswire

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2026
NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare [...]
The Ensign Group Schedules Year End 2025 Earnings Call for Thursday, February 5, 2026
02/02/2026
SAN JUAN CAPISTRANO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
02/02/2026
SAN CARLOS, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the closing of its previously announced underwritten public offering of 12 [...]
Dr. Carol Martin is the President of the Alberta Dental Association for 2026
03/02/2026
Rural Alberta dentist brings decades of practice and governance experience to her term, will focus on access to care and oral health education EDMONTON, Alberta, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Beaverlodge dentist Dr [...]
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2026
LA JOLLA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on [...]
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2026
NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2026
CAMBRIDGE, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly- [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/02/2026
FOSTER CITY, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of February 1, 2026 [...]
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
02/02/2026
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
Logan University Begins Accepting Applications for Physician Assistant (PA) Program
02/02/2026
Inaugural Cohort Scheduled to Start in January 2027 ST. LOUIS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- As a leader in integrated healthcare education, Logan University is expanding its degree offerings with the Master of [...]
Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients
02/02/2026
Detroit, MI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells , a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the expansion of its [...]
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
02/02/2026
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis [...]
IBA – Rachat d’Actions Propres
02/02/2026
Louvain-la-Neuve, Belgique, 2 février 2026 – 18h00 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules, annonce aujourd’hui le lancement d’un programme de rachat d’ [...]
EssilorLuxottica: Full-Year 2025 Results Conference Call Invitation
02/02/2026
Full-Year 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]
H.H.C. Group Releases White Paper on Independent Reviews in an AI-Driven Claims Environment
02/02/2026
ROCKVILLE, Md., Feb. 02, 2026 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.) , the leader in reducing healthcare costs by providing high-quality cost containment through claim negotiation, repricing and independent review [...]
IBA – Share buyback
02/02/2026
Louvain-la-Neuve, Belgium, February 2 nd , 2026 – 6PM CET – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today the launch of a share buyback program, [...]
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
02/02/2026
Ghent, Belgium, Feb. 02, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 2 February 2026, 6 : 00 pm CET Ghent, Belgium, 2 February 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) ( [...]
EssilorLuxottica: Full-Year 2025 Results Conference Call Invitation
02/02/2026
Full-Year 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
02/02/2026
CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss and up to 24% achieved ≥20% weight loss 1 . CagriSema achieved superior HbA 1c reduction of up to 1.91%- [...]

Pages